Prepontine cisternal routine for intrathecal targeted drug delivery in craniofacial cancer pain treatment: technical note

Intrathecal targeted drug delivery provides effective relief for cancer-related pain. However, its validation in management of craniofacial pain remains much less widely practiced, mainly due to the localized diffusion of analgesic agent with current approach. Here, we report our experience of prepo...

Full description

Bibliographic Details
Main Authors: Haocheng Zhou, Dong Huang, Dingquan Zou, Junjiao Hu, Xinning Li, Yaping Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Drug Delivery
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/10717544.2022.2134507
_version_ 1797985874523193344
author Haocheng Zhou
Dong Huang
Dingquan Zou
Junjiao Hu
Xinning Li
Yaping Wang
author_facet Haocheng Zhou
Dong Huang
Dingquan Zou
Junjiao Hu
Xinning Li
Yaping Wang
author_sort Haocheng Zhou
collection DOAJ
description Intrathecal targeted drug delivery provides effective relief for cancer-related pain. However, its validation in management of craniofacial pain remains much less widely practiced, mainly due to the localized diffusion of analgesic agent with current approach. Here, we report our experience of prepontine cisternal routine for placement and implantation of intrathecal targeted drug delivery in two cases of cancer-related craniofacial pain. Lumbar cannulation was applied and the intrathecal catheter tip was positioned at the prepontine cistern under fluoroscopic guidance during the surgical implantation. Postoperative imaging confirmed that the catheter tip was successfully placed in the prepontine cisternal space. Satisfactory control of pain was achieved after intrathecal therapy, with significant reduction of background and breakthrough cancer pain. None obvious complications were observed in this study. Thus, our novel intrathecal routine may provide an alternative option for craniofacial pain caused by tumor, who were insufficiently treated by oral analgesic agents.
first_indexed 2024-04-11T07:23:56Z
format Article
id doaj.art-1058b75898c24b83845714b93f6f95b2
institution Directory Open Access Journal
issn 1071-7544
1521-0464
language English
last_indexed 2024-04-11T07:23:56Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Drug Delivery
spelling doaj.art-1058b75898c24b83845714b93f6f95b22022-12-22T04:37:07ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642022-12-012913213321710.1080/10717544.2022.2134507Prepontine cisternal routine for intrathecal targeted drug delivery in craniofacial cancer pain treatment: technical noteHaocheng Zhou0Dong Huang1Dingquan Zou2Junjiao Hu3Xinning Li4Yaping Wang5Department of Pain Management and Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Pain, The Third Xiangya Hospital and Institute of Pain Medicine, Central South University, Changsha, Hunan, ChinaDepartment of Pain Management and Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Radiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Pain Management and Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Pain Management and Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaIntrathecal targeted drug delivery provides effective relief for cancer-related pain. However, its validation in management of craniofacial pain remains much less widely practiced, mainly due to the localized diffusion of analgesic agent with current approach. Here, we report our experience of prepontine cisternal routine for placement and implantation of intrathecal targeted drug delivery in two cases of cancer-related craniofacial pain. Lumbar cannulation was applied and the intrathecal catheter tip was positioned at the prepontine cistern under fluoroscopic guidance during the surgical implantation. Postoperative imaging confirmed that the catheter tip was successfully placed in the prepontine cisternal space. Satisfactory control of pain was achieved after intrathecal therapy, with significant reduction of background and breakthrough cancer pain. None obvious complications were observed in this study. Thus, our novel intrathecal routine may provide an alternative option for craniofacial pain caused by tumor, who were insufficiently treated by oral analgesic agents.https://www.tandfonline.com/doi/10.1080/10717544.2022.2134507Prepontine cisternalintrathecalcraniofacialcancer paintechnical note
spellingShingle Haocheng Zhou
Dong Huang
Dingquan Zou
Junjiao Hu
Xinning Li
Yaping Wang
Prepontine cisternal routine for intrathecal targeted drug delivery in craniofacial cancer pain treatment: technical note
Drug Delivery
Prepontine cisternal
intrathecal
craniofacial
cancer pain
technical note
title Prepontine cisternal routine for intrathecal targeted drug delivery in craniofacial cancer pain treatment: technical note
title_full Prepontine cisternal routine for intrathecal targeted drug delivery in craniofacial cancer pain treatment: technical note
title_fullStr Prepontine cisternal routine for intrathecal targeted drug delivery in craniofacial cancer pain treatment: technical note
title_full_unstemmed Prepontine cisternal routine for intrathecal targeted drug delivery in craniofacial cancer pain treatment: technical note
title_short Prepontine cisternal routine for intrathecal targeted drug delivery in craniofacial cancer pain treatment: technical note
title_sort prepontine cisternal routine for intrathecal targeted drug delivery in craniofacial cancer pain treatment technical note
topic Prepontine cisternal
intrathecal
craniofacial
cancer pain
technical note
url https://www.tandfonline.com/doi/10.1080/10717544.2022.2134507
work_keys_str_mv AT haochengzhou prepontinecisternalroutineforintrathecaltargeteddrugdeliveryincraniofacialcancerpaintreatmenttechnicalnote
AT donghuang prepontinecisternalroutineforintrathecaltargeteddrugdeliveryincraniofacialcancerpaintreatmenttechnicalnote
AT dingquanzou prepontinecisternalroutineforintrathecaltargeteddrugdeliveryincraniofacialcancerpaintreatmenttechnicalnote
AT junjiaohu prepontinecisternalroutineforintrathecaltargeteddrugdeliveryincraniofacialcancerpaintreatmenttechnicalnote
AT xinningli prepontinecisternalroutineforintrathecaltargeteddrugdeliveryincraniofacialcancerpaintreatmenttechnicalnote
AT yapingwang prepontinecisternalroutineforintrathecaltargeteddrugdeliveryincraniofacialcancerpaintreatmenttechnicalnote